Jiani Xu

1.1k total citations · 1 hit paper
8 papers, 566 citations indexed

About

Jiani Xu is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jiani Xu has authored 8 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jiani Xu's work include Heart Failure Treatment and Management (2 papers), Cardiac Imaging and Diagnostics (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Jiani Xu is often cited by papers focused on Heart Failure Treatment and Management (2 papers), Cardiac Imaging and Diagnostics (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Jiani Xu collaborates with scholars based in China and Australia. Jiani Xu's co-authors include Lichan Tao, Tingting Wang, Jian‐Jun Li, Fei Hua, Hong Zhang, Xiaolin Huang, Tingting Wang, Stacey Llewellyn, Judith Bauer and Glen Kennedy and has published in prestigious journals such as Clinica Chimica Acta, Bone Marrow Transplantation and Cardiovascular Diabetology.

In The Last Decade

Jiani Xu

4 papers receiving 554 citations

Hit Papers

Triglyceride-glucose index as a marker in cardiovascular ... 2022 2026 2023 2024 2022 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiani Xu China 3 313 264 209 79 59 8 566
Alejandro Díaz González-Colmenero Mexico 8 228 0.7× 124 0.5× 152 0.7× 67 0.8× 58 1.0× 15 445
Ricardo César Solís Mexico 5 198 0.6× 121 0.5× 143 0.7× 51 0.6× 57 1.0× 12 389
Weiqiang Wu China 13 223 0.7× 254 1.0× 135 0.6× 124 1.6× 47 0.8× 40 500
Victoria González‐Nava Mexico 5 193 0.6× 116 0.4× 135 0.6× 61 0.8× 45 0.8× 8 391
Haoyu Wang China 13 172 0.5× 303 1.1× 107 0.5× 152 1.9× 41 0.7× 45 505
Laura Sánchez‐Íñigo Spain 6 537 1.7× 354 1.3× 345 1.7× 123 1.6× 107 1.8× 9 857
Jan Stritzke Germany 15 126 0.4× 586 2.2× 124 0.6× 82 1.0× 50 0.8× 23 767
Tiến Hoàng Anh Vietnam 8 175 0.6× 180 0.7× 97 0.5× 41 0.5× 26 0.4× 28 345
Irene Vinagre Spain 17 481 1.5× 190 0.7× 165 0.8× 181 2.3× 64 1.1× 64 951

Countries citing papers authored by Jiani Xu

Since Specialization
Citations

This map shows the geographic impact of Jiani Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiani Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiani Xu more than expected).

Fields of papers citing papers by Jiani Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiani Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiani Xu. The network helps show where Jiani Xu may publish in the future.

Co-authorship network of co-authors of Jiani Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiani Xu. A scholar is included among the top collaborators of Jiani Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiani Xu. Jiani Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Xu, Jiani, et al.. (2025). Diagnostic performance of RAC2 combined with CT-FFR parameters in coronary heart disease. Minerva Cardiology and Angiology. 73(5). 558–565.
2.
Tao, Zhiwen, Zhenyu Lin, Lei Xu, et al.. (2025). Using higher cut-off values to diagnose acute myocardial infarction in patients with elevated hs-cTnT. Journal of Biomedical Research. 39(6). 564–564.
3.
Xu, Jiani, et al.. (2023). Nutrition support and clinical outcomes following allogeneic stem cell transplantation. Bone Marrow Transplantation. 58(10). 1137–1142. 3 indexed citations
4.
Wang, Tingting, Jiani Xu, Hong Zhang, Lichan Tao, & Xiaolin Huang. (2023). Triglyceride-glucose index for the detection of subclinical heart failure with preserved ejection fraction in patients with type 2 diabetes. Frontiers in Cardiovascular Medicine. 10. 1086978–1086978. 10 indexed citations
5.
Xu, Jiani, et al.. (2023). Insight into the role of PCSK9 in glucose metabolism. Clinica Chimica Acta. 547. 117444–117444. 2 indexed citations
6.
Tao, Lichan, Jiani Xu, Tingting Wang, Fei Hua, & Jian‐Jun Li. (2022). Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovascular Diabetology. 21(1). 68–68. 549 indexed citations breakdown →
7.
Zhang, Liquan, Jiani Xu, Zhenzhen Wang, et al.. (2014). [Application of locomotor activity test to evaluate functional injury after global cerebral ischemia in C57BL/6 mice].. PubMed. 43(3). 339–45. 1 indexed citations
8.
Xu, Jiani, Dehua Yu, & Jiangang Li. (2012). The mediating effects of psychological empowerment on leadership style and employee satisfaction in hospitals. 10. 1215–1219. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026